-transparent.png){kind=logo}
A variety of cell mutants were obtained by a single 5'-bromodeoxyuridine (BrdU) treatment of an nonproducer (NP) cell line transformed by the Kirsten strain of murine sarcoma virus (Ki-MSV). Isolation procedures of these cell See PDF for Structure mutants are described. The cell mutants obtained were classified by tumorigenic potential and shedding of Type C virus particles. The cell mutants were classified into four groups: (A) tumorigenic, without particles; (B) tumorigenic, with Type C particles; (C) nontumorigenic, without particles; and (D) nontumorigenic, with Type C particles. The tumorigenic cell lines showed variability in morphology with both flat and typical transformed appearing cell lines showing equal transplantability.
M Hatanaka, and
R Klein, and
R Toni, and
J Walker, and
R Gilden
July 1974,
The Journal of experimental medicine,
M Hatanaka, and
R Klein, and
R Toni, and
J Walker, and
R Gilden
January 1983,
Intervirology,
M Hatanaka, and
R Klein, and
R Toni, and
J Walker, and
R Gilden
April 1972,
Journal of virology,
M Hatanaka, and
R Klein, and
R Toni, and
J Walker, and
R Gilden
January 1973,
Intervirology,
M Hatanaka, and
R Klein, and
R Toni, and
J Walker, and
R Gilden
May 1972,
International journal of cancer,
M Hatanaka, and
R Klein, and
R Toni, and
J Walker, and
R Gilden
April 1980,
Journal of the National Cancer Institute,
M Hatanaka, and
R Klein, and
R Toni, and
J Walker, and
R Gilden
December 1971,
Proceedings of the National Academy of Sciences of the United States of America,
M Hatanaka, and
R Klein, and
R Toni, and
J Walker, and
R Gilden
July 1974,
Virology,
M Hatanaka, and
R Klein, and
R Toni, and
J Walker, and
R Gilden
January 1979,
Journal of virology,
M Hatanaka, and
R Klein, and
R Toni, and
J Walker, and
R Gilden
May 1975,
Virology,
